Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism.
作者： Fatima Iqbal , Wendy S Baker , Madiha I Khan , Shwetha Thukuntla , Kevin H McKinney
DOI: 10.1111/BPH.13743
关键词:
摘要: … The PCKS9 story is relatively new and will be revisited in coming years. Nevertheless, monoclonal antibodies show promise for ameliorating inflammation and related dyslipidaemia. …
utsystem.edu参考文章(258)
D. Applebaum-Bowden, W. R. Hazzard, Why women live longer than men: the biologic mechanism of the sex differential in longevity. Transactions of the American Clinical and Climatological Association. ,vol. 101, pp. 168- ,(1990)
Grazyna Wójcicka, Anna Jamroz-Wiśniewska, Jerzy Bełtowski, Krzysztof Horoszewicz, Liver X receptors (LXRs). Part II: non-lipid effects, role in pathology, and therapeutic implications. Postȩpy higieny i medycyny doświadczalnej. ,vol. 61, pp. 760- 785 ,(2007)
NAGA CHALASANI, JESSE ROMAN, RAFAEL L. JURADO, Systemic inflammatory response syndrome caused by chronic salicylate intoxication. Southern Medical Journal. ,vol. 89, pp. 479- 482 ,(1996) , 10.1097/00007611-199605000-00005
Lautermann D, Braun J, Ankylosing spondylitis--cardiac manifestations. Clinical and Experimental Rheumatology. ,vol. 20, pp. 11- 15 ,(2002)
Minori Mizoguchi, Nobuhiro Tahara, Atsuko Tahara, Yoshikazu Nitta, Norihiro Kodama, Toyoharu Oba, Kazutoshi Mawatari, Hideo Yasukawa, Hayato Kaida, Masatoshi Ishibashi, Naofumi Hayabuchi, Haruhito Harada, Hisao Ikeda, Sho-ichi Yamagishi, Tsutomu Imaizumi, Pioglitazone Attenuates Atherosclerotic Plaque Inflammation in Patients With Impaired Glucose Tolerance or Diabetes: A Prospective, Randomized, Comparator-Controlled Study Using Serial FDG PET/CT Imaging Study of Carotid Artery and Ascending Aorta Jacc-cardiovascular Imaging. ,vol. 4, pp. 1110- 1118 ,(2011) , 10.1016/J.JCMG.2011.08.007
A. L. Pasqui, L. Puccetti, G. Bova, M. Di Renzo, F. Bruni, M. Pastorelli, A. Palazzuoli, A. Auteri, Relationship between serum complement and different lipid disorders Clinical and Experimental Medicine. ,vol. 2, pp. 33- 38 ,(2002) , 10.1007/S102380200004
Yoshifumi Saisho, Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect. Endocrine‚ Metabolic & Immune Disorders-Drug Targets. ,vol. 15, pp. 196- 205 ,(2015) , 10.2174/1871530315666150316124019
Alejandro Souto, Eva Salgado, José Ramón Maneiro, Antonio Mera, Loreto Carmona, Juan J. Gómez-Reino, Lipid profile changes in patients with chronic inflammatory arthritis treated with biologic agents and tofacitinib in randomized clinical trials: a systematic review and meta-analysis. Arthritis & Rheumatism. ,vol. 67, pp. 117- 127 ,(2015) , 10.1002/ART.38894
Edwin S. L. Chan, Bruce N. Cronstein, Methotrexate—how does it really work? Nature Reviews Rheumatology. ,vol. 6, pp. 175- 178 ,(2010) , 10.1038/NRRHEUM.2010.5
Chao Zhang, Feng Gao, Hao Luo, Chun-Ting Zhang, Ren Zhang, Differential response in levels of high-density lipoprotein cholesterol to one-year metformin treatment in prediabetic patients by race/ethnicity Cardiovascular Diabetology. ,vol. 14, pp. 79- 79 ,(2015) , 10.1186/S12933-015-0240-1